4MO Homologous recombination (HR) status of platinum-responsive advanced triple-negative breast cancers (aTNBC) treated with olaparib as maintenance therapy
- Resource Type
- Abstract
- Source
- In
ESMO Open May 2023 8(1) Supplement 4 - Subject
- Language
- ISSN
- 2059-7029